Searched for
OXFORD BIOMEDICA
Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...- SII's Poonawalla makes clarion call for global certification of vaccines"Multilateral organisations such as the United Nations and the World Trade Organisation should take it upon themselves to harmonise the cer...
- AstraZeneca jab uncertainty will hit Oxford BioMedica’s revenueIn a recent report, Oxford Biomedica warned that uncertainty surrounding AstraZeneca’s Covid-19 contract will bring reduction in earnings t...
- Serum Institute to invest $68 million in UK vaccine maker Oxford BiomedicaSerum Life Sciences Ltd, a unit of India-based SII, will pick up a 3.9% stake in Oxford Biomedica as part of the deal. Oxford Biomedica, sp...
- A stock trader’s guide to the global Covid vaccine rolloutThese are some of the sectors and stocks in traders’ sights for their roles in the global vaccine rollout.
Load More